Cornerstone Capital Management Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-48,500	Closed	-$426K	–	1378
2014 Q1	$426K	Sell	48,500 -4,000	-8%	-$34.8K	0.01%	1005
2013 Q4	$430K	Buy	+52,500	New	+$416K	0.01%	952
2013 Q3	–	Sell	-16,000	Closed	-$122K	–	1332
2013 Q2	$122K	Buy	+16,000	New	+$117K	﹤0.01%	1101

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

HGI

Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Cornerstone Capital Management Holdings's RDY Position: Q2 2014 in Review

Cornerstone Capital Management Holdings sold out of Dr. Reddy's Laboratories (RDY) in Q2 2014, closing a stake of 48,500 shares — an estimated $426K sold.

Cornerstone Capital Management Holdings first reported a position in RDY in Q2 2013 and held it in 3 quarters. The position peaked at $430K in Q4 2013. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2014.

Cornerstone Capital Management Holdings reported no remaining Dr. Reddy's Laboratories position as of Q2 2014 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 48,500 Dr. Reddy's Laboratories shares in Q2 2014, an estimated $426K.
Cornerstone Capital Management Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 3 quarters.
Cornerstone Capital Management Holdings's Dr. Reddy's Laboratories position peaked at $430K in Q4 2013.
169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2014.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2014, filed 11 Aug 2014.